-
公开(公告)号：US08613764B2
公开(公告)日：2013-12-24
申请号：US12023971
申请日：2008-01-31
Applicant: Deborah Kilpatrick , Murthy Simhambhatla , Santosh Prabhu , Shawn Chin Quee
Inventor： Deborah Kilpatrick , Murthy Simhambhatla , Santosh Prabhu , Shawn Chin Quee
CPC classification number: A61F2/07 , A61B17/22 , A61B2017/22077 , A61B2017/22082 , A61F2/86 , A61F2/90 , A61F2/958 , A61F2002/075 , A61F2250/0067 , A61L27/3808 , A61L27/3843 , A61L31/16 , A61M25/0084 , A61M29/02 , A61M2025/0086
Abstract: An apparatus and method to treat vulnerable plaque. In one embodiment, the apparatus has a medical device to treat an occlusive plaque, and is also adapted to release a biologically active agent to treat vulnerable plaque located downstream from the occlusive plaque. In an alternative embodiment, the apparatus has an expandable tube attached to the inner surface of a stent, and a layer of endothelial cells seeded on the inner surface of the expandable tube. The expandable tube shields a vulnerable plaque from a body lumen.
Abstract translation: 一种治疗易损斑块的装置和方法。 在一个实施方案中，该装置具有治疗闭塞性斑块的医疗装置，并且还适于释放生物活性剂以治疗位于封闭斑块下游的易损斑块。 在替代实施例中，该装置具有连接到支架的内表面的可扩张管和接种在可扩张管的内表面上的内皮细胞层。 可扩张管屏蔽易损斑块与体腔。
-
12.发明授权公开(公告)号：US07311970B2
公开(公告)日：2007-12-25
申请号：US10944319
申请日：2004-09-17
Applicant: Eugene T. Michal , Murthy Simhambhatla , Charles D. Claude
Inventor： Eugene T. Michal , Murthy Simhambhatla , Charles D. Claude
IPC: B05D3/04 , C07D225/04 , C07D225/08 , C08F2/46 , C08J7/18
CPC classification number: C08J7/123 , A61L29/085 , A61L31/10 , A61M25/0009 , A61M25/0014 , A61M25/1027 , A61M25/1029 , A61M25/1034 , B05D1/62 , Y10S623/926 , Y10T428/26 , Y10T428/263 , Y10T428/265 , Y10T428/31504 , Y10T428/3154 , Y10T428/31544 , Y10T428/31551 , Y10T428/31663 , Y10T428/31721 , Y10T428/31855
Abstract: A medical device comprising a substrate having a plasma polymerized functionality bonded to at least a portion of the substrate. A superoxide dismutase mimic agent having a complimentary functional group to the plasma polymerized functionality is bonded to the portion of the substrate by bonding to the plasma polymerized functionality.
Abstract translation: 一种医疗装置，其包括具有结合到所述基底的至少一部分的等离子体聚合功能的基底。 通过与等离子体聚合官能团的结合，具有与等离子体聚合官能团互补的官能团的超氧化物歧化酶模拟剂与基板的该部分结合。
-
公开(公告)号：US20060062821A1
公开(公告)日：2006-03-23
申请号：US11218654
申请日：2005-09-02
Applicant: Murthy Simhambhatla , Ni Ding , Stephen Pacetti
Inventor： Murthy Simhambhatla , Ni Ding , Stephen Pacetti
IPC: A61F13/00
CPC classification number: A61L31/10 , A61L31/16 , A61L2300/114 , A61L2300/606 , A61L2300/622 , A61L2300/626 , C08L77/04
Abstract: Polycationic peptide coatings for implantable medical devices and methods of making the same are described. The methods include applying an emulsion on the device, the emulsion including a polymer and a polycationic peptide. Other methods include incorporation of the polycationic peptide in microspheres and liposomes.
-
14.发明申请公开(公告)号：US20050031874A1
公开(公告)日：2005-02-10
申请号：US10944319
申请日：2004-09-17
Applicant: Eugene Michal , Murthy Simhambhatla , Charles Claude
Inventor： Eugene Michal , Murthy Simhambhatla , Charles Claude
CPC classification number: C08J7/123 , A61L29/085 , A61L31/10 , A61M25/0009 , A61M25/0014 , A61M25/1027 , A61M25/1029 , A61M25/1034 , B05D1/62 , Y10S623/926 , Y10T428/26 , Y10T428/263 , Y10T428/265 , Y10T428/31504 , Y10T428/3154 , Y10T428/31544 , Y10T428/31551 , Y10T428/31663 , Y10T428/31721 , Y10T428/31855
Abstract: A medical device comprising a substrate having a plasma polymerized functionality bonded to at least a portion of the substrate. A superoxide dismutase mimic agent having a complimentary functional group to the plasma polymerized functionality is bonded to the portion of the substrate by bonding to the plasma polymerized functionality.
Abstract translation: 一种医疗装置，其包括具有结合到所述基底的至少一部分的等离子体聚合功能的基底。 通过与等离子体聚合官能团的结合，具有与等离子体聚合官能团互补的官能团的超氧化物歧化酶模拟剂与基板的该部分结合。
-
15.发明授权Assembly including an active matrix liquid crystal display module and having plural environmental seals 失效组件包括有源矩阵液晶显示模块并具有多个环境密封公开(公告)号：US06246459B1
公开(公告)日：2001-06-12
申请号：US09095427
申请日：1998-06-10
Applicant: Murthy Simhambhatla , David Barry , Nils Wydler
Inventor： Murthy Simhambhatla , David Barry , Nils Wydler
IPC: G02F11333
CPC classification number: G02F1/133385 , G02F1/133308
Abstract: An active matrix liquid crystal display module (10) is contained in a base (20). Improved environmental sealing is provided by a primary seal (36) along the edge of the liquid crystal display module and a secondary seal (14a, 14b) at the base. The liquid crystal display module is affixed to a cover (12) which in turn is affixed to the base, such that the liquid crystal display module is suspended in a cavity (21) in the base, spaced apart from physical contact with the base. In this way, any thermomechanical stresses that may develop in the base are not transmitted to the liquid crystal display module. Thermal contact between the liquid crystal display module and the base is made via a thermally conductive material (19), to permit efficient heat dissipation.
Abstract translation: 有源矩阵液晶显示模块（10）包含在基座（20）中。 通过沿着液晶显示模块的边缘的主要密封件（36）和在底部的辅助密封件（14a，14b）提供改进的环境密封。 液晶显示模块固定在盖子12上，盖子又固定在基座上，使得液晶显示模块悬挂在底座中的空腔（21）中，与基座的物理接触间隔开。 以这种方式，在基底中可能产生的任何热机械应力都不会传递到液晶显示模块。 通过导热材料（19）制造液晶显示模块和基座之间的热接触，以允许有效的散热。
-
Patent Agency Ranking
公开(公告)号：US08821473B2
公开(公告)日：2014-09-02
申请号：US12632612
申请日：2009-12-07
Applicant: Eugene T. Michal , Evgenia Mandrusov , Charles D. Claude , Ni Ding , Murthy Simhambhatla , Syed Faiyaz Ahmed Hossainy , Srinivasan Sridharan , Paul Consigny
Inventor： Eugene T. Michal , Evgenia Mandrusov , Charles D. Claude , Ni Ding , Murthy Simhambhatla , Syed Faiyaz Ahmed Hossainy , Srinivasan Sridharan , Paul Consigny
IPC: A61M31/00 , A61K31/7088 , A61K9/00
CPC classification number: A61K9/0019 , A61K9/0024 , A61K31/7088
Abstract: Methods, devices, kits and compositions to treat a myocardial infarction. In one embodiment, the method includes the prevention of remodeling of the infarct zone of the ventricle. In other embodiments, the method includes the introduction of structurally reinforcing agents. In other embodiments, agents are introduced into a ventricle to increase compliance of the ventricle. In an alternative embodiment, the prevention of remodeling includes the prevention of thinning of the ventricular infarct zone. In another embodiment, the prevention of remodeling and thinning of the infarct zone involves the cross-linking of collagen and prevention of collagen slipping. In other embodiments, the structurally reinforcing agent may be accompanied by other therapeutic agents. These agents may include but are not limited to pro-fibroblastic and angiogenic agents.
Abstract translation: 用于治疗心肌梗塞的方法，装置，试剂盒和组合物。 在一个实施例中，该方法包括防止脑室梗死区的重塑。 在其它实施方案中，该方法包括引入结构上增强剂。 在其它实施方案中，将药剂引入心室以增加心室的依从性。 在替代实施例中，预防重塑包括防止心室梗塞区变薄。 在另一个实施方案中，预防梗塞区的重塑和变薄包括胶原蛋白的交联和预防胶原蛋白滑脱。 在其它实施方案中，结构上增强剂可以伴随其它治疗剂。 这些药剂可以包括但不限于前成纤维细胞和血管生成剂。
-
公开(公告)号：US08652194B1
公开(公告)日：2014-02-18
申请号：US11388899
申请日：2006-03-23
Applicant: Deborah Kilpatrick , Murthy Simhambhatla , Santosh Prabhu , Shawn Chin Quee
Inventor： Deborah Kilpatrick , Murthy Simhambhatla , Santosh Prabhu , Shawn Chin Quee
IPC: A61F2/82
CPC classification number: A61F2/07 , A61B17/22 , A61B2017/22077 , A61B2017/22082 , A61F2/86 , A61F2/90 , A61F2/958 , A61F2002/075 , A61F2250/0067 , A61L27/3808 , A61L27/3843 , A61L31/16 , A61M25/0084 , A61M29/02 , A61M2025/0086
Abstract: An apparatus and method to treat vulnerable plaque. In one embodiment, the apparatus has a medical device to treat an occlusive plaque, and is also adapted to release a biologically active agent to treat vulnerable plaque located downstream from the occlusive plaque. In an alternative embodiment, the apparatus has an expandable tube attached to the inner surface of a stent, and a layer of endothelial cells seeded on the inner surface of the expandable tube. The expandable tube shields a vulnerable plaque from a body lumen.
Abstract translation: 一种治疗易损斑块的装置和方法。 在一个实施方案中，该装置具有治疗闭塞性斑块的医疗装置，并且还适于释放生物活性剂以治疗位于封闭斑块下游的易损斑块。 在替代实施例中，该装置具有连接到支架的内表面的可扩张管和接种在可扩张管的内表面上的内皮细胞层。 可扩张管屏蔽易损斑块与体腔。
-
公开(公告)号：US07641643B2
公开(公告)日：2010-01-05
申请号：US10414767
申请日：2003-04-15
Applicant: Eugene T. Michal , Evgenia Mandrusov , Charles D. Claude , Nadine Ding , Murthy Simhambhatla , Syed Faiyez Ahmed Hossainy , Srinivasan Sridharan , Paul Consigny
Inventor： Eugene T. Michal , Evgenia Mandrusov , Charles D. Claude , Nadine Ding , Murthy Simhambhatla , Syed Faiyez Ahmed Hossainy , Srinivasan Sridharan , Paul Consigny
IPC: A61M31/00
CPC classification number: A61N1/3625 , A61K9/0024 , A61K31/00 , A61K31/728 , A61K31/732 , A61K31/734 , A61K31/78 , A61K31/79 , A61K36/886 , A61K38/40 , A61K41/0042 , A61K45/06 , A61K47/02 , A61K47/34 , A61K47/60 , A61K47/62 , A61K49/0404 , A61L24/043 , A61L27/20 , A61L27/50 , A61L27/54 , A61L2430/20 , A61N1/36521 , A61K2300/00
Abstract: Methods, devices, kits and compositions to treat a myocardial infarction. In one embodiment, the method includes the prevention of remodeling of the infarct zone of the ventricle. In other embodiments, the method includes the introduction of structurally reinforcing agents. In other embodiments, agents are introduced into a ventricle to increase compliance of the ventricle. In an alternative embodiment, the prevention of remodeling includes the prevention of thinning of the ventricular infarct zone. In another embodiment, the prevention of remodeling and thinning of the infarct zone involves the cross-linking of collagen and prevention of collagen slipping. In other embodiments, the structurally reinforcing agent may be accompanied by other therapeutic agents. These agents may include but are not limited to pro-fibroblastic and angiogenic agents.
Abstract translation: 用于治疗心肌梗塞的方法，装置，试剂盒和组合物。 在一个实施例中，该方法包括防止脑室梗死区的重塑。 在其它实施方案中，该方法包括引入结构上增强剂。 在其它实施方案中，将药剂引入心室以增加心室的依从性。 在替代实施例中，预防重塑包括防止心室梗塞区变薄。 在另一个实施方案中，预防梗塞区的重塑和变薄包括胶原蛋白的交联和预防胶原蛋白滑脱。 在其它实施方案中，结构上增强剂可以伴随其它治疗剂。 这些药剂可以包括但不限于前成纤维细胞和血管生成剂。
-
19.发明授权公开(公告)号：US07470469B1
公开(公告)日：2008-12-30
申请号：US11773881
申请日：2007-07-05
Applicant: Eugene T. Michal , Murthy Simhambhatla , Charles D. Claude
Inventor： Eugene T. Michal , Murthy Simhambhatla , Charles D. Claude
IPC: B05D3/04 , C07D225/04 , C07D225/08 , C08F2/46 , C08J7/18
CPC classification number: C08J7/123 , A61L29/085 , A61L31/10 , A61M25/0009 , A61M25/0014 , A61M25/1027 , A61M25/1029 , A61M25/1034 , B05D1/62 , Y10S623/926 , Y10T428/26 , Y10T428/263 , Y10T428/265 , Y10T428/31504 , Y10T428/3154 , Y10T428/31544 , Y10T428/31551 , Y10T428/31663 , Y10T428/31721 , Y10T428/31855
Abstract: A medical device comprising a substrate having a plasma polymerized functionality bonded to at least a portion of the substrate. A superoxide dismutase mimic agent having a complimentary functional group to the plasma polymerized functionality is bonded to the portion of the substrate by bonding to the plasma polymerized functionality. The functionalities can be carboxylate, amine, or sulfate groups and/or polyethylene glycol and can optionally include crosslinking groups.
Abstract translation: 一种医疗装置，其包括具有结合到所述基底的至少一部分的等离子体聚合功能的基底。 通过与等离子体聚合官能团的结合，具有与等离子体聚合官能团互补的官能团的超氧化物歧化酶模拟剂结合到基底的该部分。 官能团可以是羧酸盐，胺或硫酸盐基团和/或聚乙二醇，并且可任选地包括交联基团。
-
公开(公告)号：US20080125851A1
公开(公告)日：2008-05-29
申请号：US12023971
申请日：2008-01-31
Applicant: Deborah Kilpatrick , Murthy Simhambhatla , Santosh Prabhu , Shawn Chin Quee
Inventor： Deborah Kilpatrick , Murthy Simhambhatla , Santosh Prabhu , Shawn Chin Quee
CPC classification number: A61F2/07 , A61B17/22 , A61B2017/22077 , A61B2017/22082 , A61F2/86 , A61F2/90 , A61F2/958 , A61F2002/075 , A61F2250/0067 , A61L27/3808 , A61L27/3843 , A61L31/16 , A61M25/0084 , A61M29/02 , A61M2025/0086
Abstract: An apparatus and method to treat vulnerable plaque. In one embodiment, the apparatus has a medical device to treat an occlusive plaque, and is also adapted to release a biologically active agent to treat vulnerable plaque located downstream from the occlusive plaque. In an alternative embodiment, the apparatus has an expandable tube attached to the inner surface of a stent, and a layer of endothelial cells seeded on the inner surface of the expandable tube. The expandable tube shields a vulnerable plaque from a body lumen.
Abstract translation: 一种治疗易损斑块的装置和方法。 在一个实施方案中，该装置具有治疗闭塞性斑块的医疗装置，并且还适于释放生物活性剂以治疗位于封闭斑块下游的易损斑块。 在替代实施例中，该装置具有连接到支架的内表面的可扩张管和接种在可扩张管的内表面上的内皮细胞层。 可扩张管屏蔽易损斑块与体腔。
-
-
-
-
-
-
-
-
-
Search Results
22
records
(took 0.039 seconds)
